High-Dose vs. Standard-Dose Influenza Vaccine and Cardiopulmonary Hospitalization or Mortality: Emulating the

Mehdi NajafZadeh1, HoJin Shin1, Sebastian Schneeweiss1

  • 1Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Summary

High-dose (HD) flu vaccines did not benefit patients in the INVESTED trial. However, real-world evidence showed HD vaccines reduced hospitalization and mortality risk in older heart patients.